Neurotrack
Neurotrack is a digital health company on a mission to transform the diagnosis and management of Alzheimer's and other dementias. The company develops turnkey tools for providers that can be easily delivered at scale to facilitate early detection of cognitive impairment and ongoing monitoring of cognitive function. Neurotrack's patient-guided, clinically-validated cognitive assessments work in the clinic or at home to fit any workflow. Neurotrack has published 27 peer-reviewed papers, holds 11 patents on its proprietary technology, and is registered as an FDA Class II medical device. For more information visit neurotrack.com. The company was founded in 2012 by Elli Kaplan and neuroscientist Dr. Stuart Zola and is based in Redwood City, California.
Domain
neurotrack.com
Country
United StatesIndustry
BiotechnologyEmployees
11-50
Last Funding
$10.0M
Founded
2011
Tech Stack (17 technologies)
Frequently Asked Questions
What technologies does Neurotrack use?+
Neurotrack uses 17 technologies including Google Analytics, Google Tag Manager, HubSpot CMS Hub.
What industry is Neurotrack in?+
Neurotrack operates in the Biotechnology industry.
Where is Neurotrack based?+
Neurotrack is headquartered in United States.
Explore More
Need this data at scale?
Get ready-to-use datasets: companies, technologies, and tech adoption signals across 3M+ websites.
Browse DatasetsData last updated: June 2026